Best Practice & Research Clinical Rheumatology
Volume 22, Issue 2 , Pages 221-238 , April 2008

Immune-mediated pathways in chronic inflammatory arthritis

  • Claire L. Gorman, BMedSci, MBBS, MRCP (Doctor)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 20 8383 4444; Fax: +44 20 8563 0399.
    • ,
  • Andrew P. Cope, BSc, PhD, MBBS, FRCP (Doctor)

References 

  1. Cope A. Rheumatoid arthritis. In: Rich , et al. editor. Clinical Immunology. New York: Elsevier; 2007;p. 52.1–52.21
  2. Steiner G. Auto-antibodies and autoreactive T-cells in rheumatoid arthritis: pathogenetic players and diagnostic tools. Clinical Reviews in Allergy & Immunology. 2007 Feb;32(1):23–36
  3. Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annual Review of Immunology. 2003;21:139–176
  4. Cawston TE, Wilson AJ. Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. Best Practice & Research. Clinical Rheumatology. 2006 Oct;20(5):983–1002
  5. Seyler TM, Park YW, Takemura S, et al. BLyS and APRIL in rheumatoid arthritis. The Journal of Clinical Investigation. 2005 Nov;115(11):3083–3092
  6. Janeway CA, Medzhitov R. Innate immune recognition. Annual Review of Immunology. 2002;20:197–216
  7. Beutler B, Jiang Z, Georgel P, et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annual Review of Immunology. 2006;24:353–389
  8. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nature Reviews. Immunology. 2007 Mar;7(3):179–190
  9. Brentano F, Kyburz D, Schorr O, et al. The role of Toll-like receptor signalling in the pathogenesis of arthritis. Cellular Immunology. 2005 Feb;233(2):90–96
  10. Seibl R, Birchler T, Loeliger S, et al. Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. American Journal of Pathology. 2003 Apr;162(4):1221–1227
  11. Roelofs MF, Joosten LA, Abdollahi-Roodsaz S, et al. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and co-stimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis & Rheumatism. 2005 Aug;52(8):2313–2322
  12. Abdollahi-Roodsaz S, Joosten LA, Roelofs MF, et al. Inhibition of toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis & Rheumatism. 2007 Sep;56(9):2957–2967
  13. Sacre SM, Andreakos E, Kiriakidis S, et al. The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. American Journal of Pathology. 2007 Feb;170(2):518–525
  14. Wagner H. Endogenous TLR ligands and autoimmunity. Advances in Immunology. 2006;91:159–173
  15. Smith MD, Barg E, Weedon H, et al. Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints. Annals of the Rheumatic Diseases. 2003 Apr;62(4):303–307
  16. Szekanecz Z, Kim J, Koch AE. Chemokines and chemokine receptors in rheumatoid arthritis. Seminars in Immunology. 2003 Feb;15(1):15–21
  17. van der Voort R, van Lieshout AW, Toonen LW, et al. Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints. Arthritis & Rheumatism. 2005 May;52(5):1381–1391
  18. Radstake TR, van der Voort R, ten Brummelhuis M, et al. Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors. Annals of the Rheumatic Diseases. 2005 Mar;64(3):359–367
  19. van Lieshout AW, Fransen J, Flendrie M, et al. Circulating levels of the chemokine CCL18 but not CXCL16 are elevated and correlate with disease activity in rheumatoid arthritis. Annals of the Rheumatic Diseases. 2007 Oct;66(10):1334–1338
  20. Kim KW, Cho ML, Kim HR, et al. Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L-CD40 interaction. Arthritis & Rheumatism. 2007 Apr;56(4):1076–1086
  21. Amin MA, Mansfield PJ, Pakozdi A, et al. Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways. Arthritis & Rheumatism. 2007 Jun;56(6):1787–1797
  22. Nanki T, Hayashida K, El-Gabalawy HS, et al. Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. Journal of Immunology. 2000 Dec 1;165(11):6590–6598
  23. Kanbe K, Takagishi K, Chen Q. Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4. Arthritis & Rheumatism. 2002 Jan;46(1):130–137
  24. Vergunst CE, van de Sande MG, Lebre MC, Tak PP. The role of chemokines in rheumatoid arthritis and osteoarthritis. Scandinavian Journal of Rheumatology. 2005 Nov–Dec;34(6):415–425
  25. Takemura S, Braun A, Crowson C, et al. Lymphoid neogenesis in rheumatoid synovitis. Journal of Immunology. 2001 Jul 15;167(2):1072–1080
  26. Haringman JJ, Smeets TJ, Reinders-Blankert P, Tak PP. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Annals of the Rheumatic Diseases. 2006 Mar;65(3):294–300
  27. Yamazaki S, Inaba K, Tarbell KV, Steinman RM. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. Immunological Reviews. 2006 Aug;212:314–329
  28. Lutzky V, Hannawi S, Thomas R. Cells of the synovium in rheumatoid arthritis. Dendritic cells. Arthritis Research & Therapy. 2007 Sep 7;9(4):219
  29. Bailey SL, Schreiner B, McMahon EJ, Miller SD. CNS myeloid DCs presenting endogenous myelin peptides ‘preferentially’ polarize CD4+ T(H)-17 cells in relapsing EAE. Nature Immunology. 2007 Feb;8(2):172–180
  30. Leung BP, Conacher M, Hunter D, et al. A novel dendritic cell-induced model of erosive inflammatory arthritis: distinct roles for dendritic cells in T cell activation and induction of local inflammation. Journal of Immunology. 2002 Dec 15;169(12):7071–7077
  31. Eriksson U, Ricci R, Hunziker L, et al. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nature Medicine. 2003 Dec;9(12):1484–1490
  32. Marshak-Rothstein A, Rifkin IR. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annual Review of Immunology. 2007;25:419–441
  33. van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, et al. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Annals of the Rheumatic Diseases. 2007 Aug;66(8):1008–1014
  34. Sakaguchi N, Takahashi T, Hata H, et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature. 2003 Nov 27;426(6965):454–460
  35. Yoshitomi H, Sakaguchi N, Kobayashi K, et al. A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. The Journal of Experimental Medicine. 2005 Mar 21;201(6):949–960
  36. Hirota K, Hashimoto M, Yoshitomi H, et al. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. The Journal of Experimental Medicine. 2007 Jan 22;204(1):41–47
  37. Horai R, Nakajima A, Habiro K, et al. TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice. The Journal of Clinical Investigation. 2004 Dec;114(11):1603–1611
  38. Atsumi T, Ishihara K, Kamimura D, et al. A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis. The Journal of Experimental Medicine. 2002 Oct 7;196(7):979–990
  39. Olofsson P, Holmberg J, Tordsson J, et al. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nature Genetics. 2003 Jan;33(1):25–32
  40. Hultqvist M, Backlund J, Bauer K, et al. Lack of reactive oxygen species breaks T cell tolerance to collagen type II and allows development of arthritis in mice. Journal of Immunology. 2007 Aug 1;179(3):1431–1437
  41. Constantinescu CS, Wysocka M, Hilliard B, et al. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. Journal of Immunology. 1998 Nov 1;161(9):5097–5104
  42. Segal BM, Dwyer BK, Shevach EM. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. The Journal of Experimental Medicine. 1998 Feb 16;187(4):537–546
  43. Cua DJ, Sherlock J, Chen Y, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003 Feb 13;421(6924):744–748
  44. Murphy CA, Langrish CL, Chen Y, et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. The Journal of Experimental Medicine. 2003 Dec 15;198(12):1951–1957
  45. Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. The Journal of Experimental Medicine. 2005 Jan 17;201(2):233–240
  46. Kolls JK, Lindén A. Interleukin-17 family members and inflammation. Immunity. 2004 Oct;21(4):467–476
  47. Aggarwal S, Ghilardi N, Xie MH, et al. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. The Journal of Biological Chemistry. 2003 Jan 17;278(3):1910–1914
  48. Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunology. 2005 Nov;6(11):1123–1132
  49. Veldhoen M, Hocking RJ, Atkins CJ, et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006 Feb;24(2):179–189
  50. Ivanov , McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006 Sep 22;126(6):1121–1133
  51. Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional features of human Th17 cells. The Journal of Experimental Medicine. 2007 Aug 6;204(8):1849–1861
  52. Wilson NJ, Boniface K, Chan JR, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nature Immunology. 2007 Sep;8(9):950–957
  53. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nature Immunology. 2007 Sep;8(9):942–949
  54. Acosta-Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nature Immunology. 2007 Jun;8(6):639–646
  55. Sato W, Aranami T, Yamamura T. Cutting edge: Human Th17 cells are identified as bearing CCR2+CCR5− phenotype. Journal of Immunology. 2007 Jun 15;178(12):7525–7529
  56. Chabaud M, Durand JM, Buchs N, et al. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis & Rheumatism. 1999 May;42(5):963–970
  57. Kotake S, Udagawa N, Takahashi N, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. The Journal of Clinical Investigation. 1999 May;103(9):1345–1352
  58. Hwang SY, Kim HY. Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. Molecules and Cells. 2005 Apr 30;19(2):180–184
  59. Van Bezooijen RL, Van Der Wee-Pals L, Papapoulos SE, Löwik CW. Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro. Annals of the Rheumatic Diseases. 2002 Oct;61(10):870–876
  60. Fossiez F, Djossou O, Chomarat P, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. The Journal of Experimental Medicine. 1996 Jun 1;183(6):2593–2603
  61. Yago T, Nanke Y, Kawamoto M, et al. IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats. Arthritis Research & Therapy. 2007 Sep 23;9(5):R96
  62. Jovanovic DV, Martel-Pelletier J, Di Battista JA, et al. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. Arthritis & Rheumatism. 2000 May;43(5):1134–1144
  63. Hirano T, Matsuda T, Turner M, et al. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. European Journal of Immunology. 1988 Nov;18(11):1797–1801
  64. Chabaud M, Garnero P, Dayer JM, et al. Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine. 2000 Jul;12(7):1092–1099
  65. Maini RN, Taylor PC, Szechinski J, et al. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis & Rheumatism. 2006 Sep;54(9):2817–2829
  66. Woo P, Wilkinson N, Prieur AM, et al. Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Research & Therapy. 2005;7(6):R1281–R1288
  67. Vos K, Thurlings RM, Wijbrandts CA, et al. Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis. Arthritis & Rheumatism. 2007 Mar;56(3):772–778
  68. Taylor PC, Plater-Zyberk C, Maini RN. The role of the B cells in the adoptive transfer of collagen-induced arthritis from DBA/1 (H-2q) to SCID (H-2d) mice. European Journal of Immunology. 1995 Mar;25(3):763–769
  69. Nandakumar KS, Bäcklund J, Vestberg M, Holmdahl R. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells. Arthritis Research & Therapy. 2004;6(6):R544–R550
  70. Nandakumar KS, Holmdahl R. Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis. Arthritis Research & Therapy. 2006;8(6):223
  71. Maccioni M, Zeder-Lutz G, Huang H, et al. Arthritogenic monoclonal antibodies from K/BxN mice. The Journal of Experimental Medicine. 2002 Apr 15;195(8):1071–1077
  72. Bobbio-Pallavicini F, Alpini C, Caporali R, et al. Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment. Arthritis Research & Therapy. 2004;6(3):R264–R272
  73. Bugatti S, Codullo V, Caporali R, Montecucco C. B cells in rheumatoid arthritis. Autoimmunity Reviews. 2007 Aug;6(7):482–487
  74. O'Neill SK, Shlomchik MJ, Glant TT, et al. Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. Journal of Immunology. 2005 Mar 15;174(6):3781–3788
  75. Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. The Journal of Experimental Medicine. 2003 Feb 17;197(4):489–501
  76. Mackay F, Woodcock SA, Lawton P, et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. The Journal of Experimental Medicine. 1999 Dec 6;190(11):1697–1710
  77. Tan SM, Xu D, Roschke V, et al. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis & Rheumatism. 2003 Apr;48(4):982–992
  78. Cambridge G, Stohl W, Leandro MJ, et al. Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse. Arthritis & Rheumatism. 2006 Mar;54(3):723–732
  79. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. Journal of Immunology. 1995 Aug 1;155(3):1151–1164
  80. Zheng Y, Rudensky AY. FoxP3 in control of the regulatory T cell lineage. Nature Immunology. 2007 May;8(5):457–462
  81. Ono M, Yaguchi H, Ohkura N, et al. FoxP3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature. 2007 Apr 5;446(7136):685–689
  82. Zheng Y, Josefowicz SZ, Kas A, et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature. 2007 Feb 22;445(7130):936–940
  83. Yamaguchi T, Hirota K, Nagahama K, et al. Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity. 2007 Jul;27(1):145–159
  84. Morgan ME, Flierman R, van Duivenvoorde LM, et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis & Rheumatism. 2005 Jul;52(7):2212–2221
  85. van Amelsfort JM, Jacobs KM, Bijlsma JW, et al. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis & Rheumatism. 2004 Sep;50(9):2775–2785
  86. Behrens F, Himsel A, Rehart S, et al. Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis. Annals of the Rheumatic Diseases. 2007 Sep;66(9):1151–1156
  87. Ehrenstein MR, Evans JG, Singh A, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. The Journal of Experimental Medicine. 2004 Aug 2;200(3):277–285
  88. Nadkarni S, Mauri C, Ehrenstein MR. Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. The Journal of Experimental Medicine. 2007 Jan 22;204(1):33–39
  89. Valencia X, Stephens G, Goldbach-Mansky R, et al. TNF downmodulates the function of human CD4+ CD25hi T-regulatory cells. Blood. 2006 Jul 1;108(1):253–261
  90. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. The New England Journal of Medicine. 1978 Apr 20;298(16):869–871
  91. du Montcel ST, Michou L, Petit-Teixeira E, et al. New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility. Arthritis & Rheumatism. 2005 Apr;52(4):1063–1068
  92. Huizinga TW, Amos CI, van der Helm-van Mil AH, et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis & Rheumatism. 2005 Nov;52(11):3433–3438
  93. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007 Jun 7;447(7145):661–678
  94. Plenge RM, Seielstad M, Padyukov L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis – a genomewide study. The New England Journal of Medicine. 2007 Sep 20;357(12):1199–1209
  95. Cloutier JF, Veillette A. Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. The EMBO Journal. 1996 Sep 16;15(18):4909–4918
  96. Hasegawa K, Martin F, Huang G, et al. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science. 2004 Jan30;303(5658):685–689
  97. Vang T, Congia M, Macis MD, et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nature Genetics. 2005 Dec;37(12):1317–1319
  98. Remmers EF, Plenge RM, Lee AT, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. The New England Journal of Medicine. 2007 Sep 6;357(10):977–986
  99. Watford WT, Hissong BD, Bream JH, et al. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunological Reviews. 2004 Dec;202:139–156
  100. Prots I, Skapenko A, Wendler J, et al. Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis. Arthritis & Rheumatism. 2006 May;54(5):1491–1500

PII: S1521-6942(08)00004-1

doi: 10.1016/j.berh.2008.01.003

Best Practice & Research Clinical Rheumatology
Volume 22, Issue 2 , Pages 221-238 , April 2008

Article Tools